SAMRATPHPharmaceuticals
Samrat Pharmachem Ltd — PE Ratio & Valuation Analysis
₹194.95
-7.93%
Current P/E48.58xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E54.7x11.2% below avg
⚠️
52.9% Premium to Industry
SAMRATPH P/E 48.58x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | ₹7.00 | ₹383 | 54.7x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Samrat Pharmachem Ltd Valuation
Samrat Pharmachem Ltd (SAMRATPH) currently trades at 48.58x earnings. The Pharmaceuticals sector average PE is 31.77x. SAMRATPH commands a premium, reflecting high growth expectations. Historically, SAMRATPH has traded at an average PE of 54.7x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
10.07%
Dividend Yield
0.41%
More on Samrat Pharmachem Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.